Pull to refresh
Logo
Daily Brief
Following
Why Sign Up
KT

Kweli Thompson

Operating Unit President, Cardiac Rhythm Management, Medtronic

Appears in 1 story

Stories

Medtronic wins first FDA approval for a defibrillation lead that paces through the heart's natural wiring

New Capabilities

Leading Medtronic's cardiac rhythm division

For decades, implantable defibrillators have saved lives by shocking dangerously fast heart rhythms back to normal — but the leads that deliver those shocks also pace the heart in an unnatural pattern that can itself cause damage over time. Medtronic's OmniaSecure lead, now cleared by the Food and Drug Administration (FDA) for placement in the left bundle branch area, is the first defibrillation lead that can also pace through the heart's own electrical wiring, closely mimicking natural heartbeats.

Updated 3 hours ago